| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/27/2002 | EP1190708A1 Medical use of substances |
| 03/27/2002 | EP1190249A2 Compounds and methods to enhance raav transduction |
| 03/27/2002 | EP1190248A1 Screening methods for compounds which affect melanogenesis |
| 03/27/2002 | EP1190083A2 Dna constructs based on the eif4a gene promoter |
| 03/27/2002 | EP1190082A1 Method of inducing angiogenesis by micro-organs |
| 03/27/2002 | EP1190072A2 22012, a novel human carboxypeptidase |
| 03/27/2002 | EP1190071A2 17867, a novel human aminopeptidase |
| 03/27/2002 | EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides |
| 03/27/2002 | EP1190059A1 Sgip peptides |
| 03/27/2002 | EP1190057A1 Cloning and expression of a novel 5-ht4 receptor |
| 03/27/2002 | EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1190050A2 Human transcriptional regulator proteins |
| 03/27/2002 | EP1190038A2 Bacterial protection against stress |
| 03/27/2002 | EP1189946A1 ANTI-$g(a) v?$g(b)3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE |
| 03/27/2002 | EP1189941A1 Neuromedin b and somatostatin receptor agonists |
| 03/27/2002 | EP1189939A1 Bh3 modified peptides |
| 03/27/2002 | EP1189931A2 Peptide compounds that bind her2 |
| 03/27/2002 | EP1189930A1 INHIBITORS OF THE INTEGRIN AlPHA V BETA 6 |
| 03/27/2002 | EP1189929A2 Factor viia inhibitors |
| 03/27/2002 | EP1189924A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 03/27/2002 | EP1189922A1 Steroid derivatives |
| 03/27/2002 | EP1189916A2 N-pyrazole a 2a receptor agonists |
| 03/27/2002 | EP1189907A1 Thienopyrimidines as phosphodiesterase inhibitors |
| 03/27/2002 | EP1189905A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189904A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189902A1 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist |
| 03/27/2002 | EP1189901A1 Oxazaheterocycles as protease inhibitors |
| 03/27/2002 | EP1189899A1 Pyrazinone thrombin inhibitors |
| 03/27/2002 | EP1189896A1 Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa |
| 03/27/2002 | EP1189895A1 Thiazole and oxazole derivatives and their pharmaceutical use |
| 03/27/2002 | EP1189892A1 Melamine derivatives as potent anti-cancer agents |
| 03/27/2002 | EP1189889A1 Compositions and methods for inhibiting cell death |
| 03/27/2002 | EP1189888A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS |
| 03/27/2002 | EP1189887A2 Process for preparing 10,11-methanobenzosuberane derivatives |
| 03/27/2002 | EP1189883A2 Substituted pyrrolidines as cell adhesion inhibitors |
| 03/27/2002 | EP1189882A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor |
| 03/27/2002 | EP1189879A1 INHIBITORS OF FACTOR Xa |
| 03/27/2002 | EP1189862A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
| 03/27/2002 | EP1189641A2 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 03/27/2002 | EP1189640A1 Pharmaceutical complex |
| 03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 03/27/2002 | EP1189626A1 Method for preventing tumoral growth |
| 03/27/2002 | EP1189623A2 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/27/2002 | EP1189620A1 Formulation comprising testosteron undecanoate and castor oil |
| 03/27/2002 | EP1189618A1 Thrombin inhibitors |
| 03/27/2002 | EP1189615A2 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 03/27/2002 | EP1189613A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP1189611A1 Cancer therapy |
| 03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
| 03/27/2002 | EP1189604A2 Zinc ionophores as anti-apoptotic agents |
| 03/27/2002 | EP1189596A1 Pharmaceutical composition for nasally administering water-soluble active substances |
| 03/27/2002 | EP1189585A1 Cosmetic skin care compositions containing cumic alcohol |
| 03/27/2002 | EP1064284B1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
| 03/27/2002 | EP1023299B1 Combined generation of phosphinic acid derivatives |
| 03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
| 03/27/2002 | EP0946503B1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 03/27/2002 | EP0888293B1 N-acylaminoalkylhydrazinecarboximidamides |
| 03/27/2002 | EP0873336B1 Antagonists of gonadotropin releasing hormone |
| 03/27/2002 | EP0869809B1 Oxidized glutathione as cytokine and hemopoietic factor endogenous production enhancer |
| 03/27/2002 | EP0865421B1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 03/27/2002 | EP0843661B1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 03/27/2002 | EP0792153B1 Compositions containing lazaroids and their use for preventing adhesions |
| 03/27/2002 | EP0782574B1 Bicyclic carboxamides as 5-ht1a receptors ligands |
| 03/27/2002 | EP0766670B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 03/27/2002 | EP0734255B1 Novel potassium channel agonist produced from trichoderma virens |
| 03/27/2002 | EP0730470B1 Improved interferon polymer conjugates |
| 03/27/2002 | EP0705272B1 Novel process for preparing 17 beta-substituted 4-azaandrostane derivatives |
| 03/27/2002 | CN1342206A Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
| 03/27/2002 | CN1342202A Soluble receptor BR43X2 and methods for using them for therapy |
| 03/27/2002 | CN1342196A Bifidobacterium in treatment of inflammatory disease |
| 03/27/2002 | CN1342169A Oxetanone derivatives |
| 03/27/2002 | CN1342167A Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 03/27/2002 | CN1342165A Neurotrophic growth factor |
| 03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1342153A Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in production of medicaments |
| 03/27/2002 | CN1342151A 喹啉和喹喔啉化合物 Quinoline and quinoxaline compounds |
| 03/27/2002 | CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 03/27/2002 | CN1342146A Substituted 1-oxo-and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels |
| 03/27/2002 | CN1342140A 硫代酰胺衍生物 Thioamide derivatives |
| 03/27/2002 | CN1342090A Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular disease |
| 03/27/2002 | CN1342083A Uses of 1-amino-3-(N,N-dimethylamino)propylidene-1,1-bisphosphonic acid |
| 03/27/2002 | CN1342077A Inhibition of formation of vascular hyperpermeability |
| 03/27/2002 | CN1342072A Method for preventing or delaying catheter-based revascularization |
| 03/27/2002 | CN1342070A Binding partners for 5-HT5 receptors for treatment of migraine |
| 03/27/2002 | CN1342064A Soy depigmenting and skin care compositions |
| 03/27/2002 | CN1341599A Novel benzodiazine compound, its preparation method and medicine composition containing them |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1341433A Compound Yanghuo granules |
| 03/27/2002 | CN1081672C Fungicdal methods and compositions for killing yeast and sporular microorganisms |
| 03/27/2002 | CN1081638C Thienopyrimidines |
| 03/27/2002 | CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines |
| 03/27/2002 | CN1081632C Form III crystalline (R-(R*,R*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CN1081624C Benzamide analogs, useful as PARP (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors |
| 03/27/2002 | CN1081462C Narctic Chinese patent drug |